GSK Warns Pharmacists Of Ziagen, Combivir Mix Up
This article was originally published in The Pink Sheet Daily
FDA issues a MedWatch alert April 10 advising of misbranded bottles of the HIV drug Combivir containing Ziagen instead.
You may also be interested in...
The agency will require pedigrees to trace transactions back to the authorized distributor of record while a preliminary injunction is in effect.
The virtual J.P. Morgan Healthcare meeting was missing the usual energy but still had substance.
US vaccination campaign will pick up speed now that access is broadening, leaders from Operation Warp Speed, Pfizer, Moderna, McKesson and CVS Health say at a J.P. Morgan panel discussion.